Sean Ainsworth
Directeur/Membre du Conseil chez OCUPHIRE PHARMA, INC.
Fortune : 148 441 $ au 31/05/2024
Postes actifs de Sean Ainsworth
Sociétés | Poste | Début | Fin |
---|---|---|---|
OCUPHIRE PHARMA, INC. | Directeur/Membre du Conseil | 01/04/2018 | - |
Independent Dir/Board Member | 01/04/2018 | - | |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Directeur Général | 01/01/2009 | - |
Président | 01/01/2009 | - | |
Fondateur | 01/01/2009 | - | |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Directeur Général | 05/01/2018 | - |
Président | 05/01/2018 | - | |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Président | 01/01/2021 | - |
Fondateur | 01/01/2021 | - |
Historique de carrière de Sean Ainsworth
Anciens postes connus de Sean Ainsworth
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ainsworth Bioconsulting LLC | Fondateur | 01/01/2004 | 01/06/2012 |
Corporate Officer/Principal | 01/01/2004 | 01/06/2012 | |
Compendia Bioscience, Inc.
Compendia Bioscience, Inc. Information Technology ServicesTechnology Services Compendia Bioscience, Inc. provides information solutions for oncology drug discovery. The company was founded by Daniel D. Rhodes and Arul Chinnaiyan in February 2006 and is headquartered in Canton, MI. | Fondateur | 01/01/2006 | - |
Genevivo LLC | Directeur Général | - | - |
Formation de Sean Ainsworth
University of California San Diego | Undergraduate Degree |
Washington University in St. Louis | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Founder | 4 |
Chief Executive Officer | 3 |
Chairman | 3 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
OCUPHIRE PHARMA, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Health Technology |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Health Services |
Ainsworth Bioconsulting LLC | |
Genevivo LLC | |
Compendia Bioscience, Inc.
Compendia Bioscience, Inc. Information Technology ServicesTechnology Services Compendia Bioscience, Inc. provides information solutions for oncology drug discovery. The company was founded by Daniel D. Rhodes and Arul Chinnaiyan in February 2006 and is headquartered in Canton, MI. | Technology Services |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Commercial Services |
- Bourse
- Insiders
- Sean Ainsworth
- Expérience